Literature DB >> 9517567

Mouse resident microglia: isolation and characterization of immunoregulatory properties with naïve CD4+ and CD8+ T-cells.

C E Havenith1, D Askew, W S Walker.   

Abstract

We describe a non-enzymatic procedure designed to isolate in high purity resident microglia from the brains of normal mice. This procedure allowed for the characterization of the cells without concern that their surface features had been enzymatically altered during tissue processing. A cell population was obtained and judged to consist primarily of microglia because essentially all the cells were Mac-1+, Mac-3+, F4/80+, CD44+, CD54+, and CD86+, and they expressed CD45 with a mean fluorescence intensity value of about one-half that of tissue macrophages. The cells also expressed marginal levels of MHC class I, CD14, CD40, and CD80, but lacked detectable MHC class II, CD4, CD8, CD45R, and CD102 molecules. Molecular phenotyping revealed that the purified microglial population contained mRNA transcripts encoding the receptor for colony stimulating factor-1 (CSF-1), the macrophage growth factor, and contained few, if any, transcripts for glial fibrillary acidic protein, an astrocyte-specific marker. Ex vivo, the microglia constitutively stimulated, in the mixed leukocyte reaction, the proliferation of naive allogeneic CD8+, but not CD4+ T-cells. However, they failed to present a protein antigen to naive antigen-specific CD4+ T-cells unless pretreated with interferon-gamma, a response that was inhibited by antibodies to CD86. Agar-cloning experiments confirmed that normal mouse brain contains a CSF-1-responsive cell that gave rise to cells with identical immunophenotypic characteristics as freshly isolated resident microglia. Moreover, the microglial progenitor cell located in a density fraction that was different from that containing the mature resident microglia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9517567

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  19 in total

1.  Generation of microglial cells from mouse embryonic stem cells.

Authors:  Clara Beutner; Kristin Roy; Bettina Linnartz; Isabella Napoli; Harald Neumann
Journal:  Nat Protoc       Date:  2010-08-05       Impact factor: 13.491

2.  T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis.

Authors:  Sara Abromson-Leeman; Rod Bronson; Yi Luo; Michael Berman; Rebecca Leeman; Joshua Leeman; Martin Dorf
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 3.  Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.

Authors:  Burkhard Becher; Ingo Bechmann; Melanie Greter
Journal:  J Mol Med (Berl)       Date:  2006-06-14       Impact factor: 4.599

4.  Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy.

Authors:  Katharina Schindowski; Anne Eckert; Jürgen Peters; Corinna Gorriz; Uta Schramm; Thomas Weinandi; Konrad Maurer; Lutz Frölich; Walter E Müller
Journal:  Neuromolecular Med       Date:  2007-10-26       Impact factor: 3.843

5.  Peripheral dendritic cells are essential for both the innate and adaptive antiviral immune responses in the central nervous system.

Authors:  Christina D Steel; Suzanne M Hahto; Richard P Ciavarra
Journal:  Virology       Date:  2009-03-04       Impact factor: 3.616

6.  Critical role of microglial CD40 in the maintenance of mechanical hypersensitivity in a murine model of neuropathic pain.

Authors:  Ling Cao; Christopher D Palmer; Jennifer T Malon; Joyce A De Leo
Journal:  Eur J Immunol       Date:  2009-12       Impact factor: 5.532

7.  APOE3, but not APOE4, bone marrow transplantation mitigates behavioral and pathological changes in a mouse model of Alzheimer disease.

Authors:  Yue Yang; Eiron Cudaback; Nikolas L Jorstad; Jake F Hemingway; Catherine E Hagan; Erica J Melief; Xianwu Li; Tom Yoo; Shawn B Khademi; Kathleen S Montine; Thomas J Montine; C Dirk Keene
Journal:  Am J Pathol       Date:  2013-07-04       Impact factor: 4.307

Review 8.  Alternative Abeta immunotherapy approaches for Alzheimer's disease.

Authors:  Terrence Town
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-04       Impact factor: 4.388

9.  Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein/cathepsin A under control of the colony-stimulating factor-1 receptor promoter.

Authors:  C N Hahn; M del Pilar Martin; X Y Zhou; L W Mann; A d'Azzo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  Role of peripheral immune response in microglia activation and regulation of brain chemokine and proinflammatory cytokine responses induced during VSV encephalitis.

Authors:  Christina D Steel; Kimberly Breving; Susan Tavakoli; Woong-Ki Kim; Larry D Sanford; Richard P Ciavarra
Journal:  J Neuroimmunol       Date:  2013-12-11       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.